abstract |
The present invention provides a class of binding proteins that bind to and inhibit the hepatocyte growth factor (HGF), in particular human HGF. The binding protein can be used as a diagnostic and / or therapeutic agent. The binding proteins can be used in the treatment of certain HGF responsive disorders, such as certain HGF responsive tumors, with respect to their therapeutic activity. |